Health

New COVID reinforcements approved: priority to protect vulnerable populations

New COVID reinforcements approved: priority to protect vulnerable populations

Related media - News 24 hours The Food and Drug Administration (FDA) on Thursday greenlit a new round of annual COVID-19 vaccines, clearing the way for Americans of all ages to receive updated protection against the current summer surge. Vaccine giants Pfizer and Moderna will begin distributing doses to health care workers within days. These vaccines target the dominant variant that emerged this spring, although newer, more closely related strains are now circulating. All of these variants appear to be more transmissible than previous ones. The new boosters offer a critical lifeline for vulnerable populations, especially older adults, who have…
Read More
Introducing Neffy: A Revolutionary Nasal Spray, an Alternative to Needle Allergy Treatments

Introducing Neffy: A Revolutionary Nasal Spray, an Alternative to Needle Allergy Treatments

More news - Breaking news In the realm of medical advances, a significant breakthrough has emerged with the introduction of Neffy, a nasal spray that has received approval from the Food and Drug Administration. This innovative device stands out as the pioneering needle-free option for managing severe allergic reactions, offering significant relief to those with a deep fear of the injections typically associated with emergency treatments like the EpiPen. Dr. Michael Blaiss, a respected allergist at the Medical College of Georgia, highlights a common scenario in his practice: Patients are often reluctant to use traditional autoinjectors during allergy emergencies. Their…
Read More
Financial woes hit data analytics firm over controversial practices

Financial woes hit data analytics firm over controversial practices

More news - Breaking news MultiPlan, a key player in the health insurance industry credited with helping major insurers save billions through minimized medical reimbursements, is currently going through a tumultuous period of increased regulatory and financial scrutiny. The New York-based company, which influences more than 100,000 health plans covering more than 60 million people, has come under fire for practices that could leave patients with large medical bills. Recent investigations have shed a harsh light on MultiPlan’s marketing tactics, which often result in insurers paying health care providers significantly less than they are charged. This strategy, while financially advantageous…
Read More
WHO issues global health alert for Mpox virus as cases rise in Africa

WHO issues global health alert for Mpox virus as cases rise in Africa

More news - Recent news The World Health Organization (WHO) has stepped up its response to the mpox outbreak by declaring it a global health emergency. The declaration came on Wednesday, marking the second such declaration in the past three years as the virus rapidly spreads to multiple African nations. Currently, the Democratic Republic of the Congo is experiencing the most severe impact of the outbreak, with a reported count of 15,600 cases and 537 deaths. The current outbreak has surpassed the severity of the 2022 episode, during which a similar emergency was declared. Mpox, formerly known as monkeypox, was…
Read More
MDMA Therapy Setback: Journal Retracts Study After FDA Rejects Drug

MDMA Therapy Setback: Journal Retracts Study After FDA Rejects Drug

More news - News 24 hours Three research papers exploring MDMA-assisted therapy for PTSD have been retracted by the journal Psychopharmacology. This follows the recent rejection of MDMA for this use by the Food and Drug Administration (FDA). The retracted studies, written by researchers affiliated with Lykos Therapeutics, the company behind the rejected treatment application, were found to involve unethical conduct at one of the research sites. Lykos, however, maintains that the retracted research was not part of their submission to the FDA. This development adds another layer of complexity to the ongoing debate over MDMA-assisted therapy. While some research…
Read More
Blood Clotting Risk Doubles With Erythritol Consumption: Insights From Pilot Study

Blood Clotting Risk Doubles With Erythritol Consumption: Insights From Pilot Study

Related media - Breaking news A recent pilot study found that drinking a beverage containing erythritol (an artificial sweetener used to boost the content of stevia and monk fruit and to sweeten low-carb ketogenic products) more than doubled the risk of blood clots in 10 healthy individuals. Blood clots can break off from blood vessels and travel to the heart, triggering a heart attack, or the brain, causing a stroke. Previous research has linked erythritol to an increased risk of stroke, heart attack, and death. Dr. Stanley Hazen, lead author of the study and director of the Cardiovascular Diagnostic and…
Read More